Dr. Eva Feldman to address Michigan Israel Business Bridge Nov. 12 in Grand Rapids
Taubman Institute Director Dr. Eva Feldman will address a special event at the Van Andel Institute in Grand Rapids on Monday, Nov. 12. The meeting is a special networking luncheon with the Michigan Israel Business Bridge, a non-profit association that promotes economic growth in Michigan and Israel.
Dr. Feldman, the Russell N. DeJong professor of neurology at the University of Michigan and leader of the first-ever stem cell trial in patients with ALS, will tell the groups about her groundbreaking collaboration with another stem cell pioneer, Benjamin E. Reubinoff, M.D., Ph.D., of Hadassah University Hospital in Jerusalem. Her talk is entitled "U-M and Hadassah: Engineering stem cells to decode a deadly disease."
The luncheon will take place from noon to 1:30 p.m.; registration is required by Nov. 6. The charge for MIBB members is $30 or $35 for non-members. For complete details, click here.
11 Taubman Scholars named to "Best Doctors in America" list
They're among 493 U-M physicians to receive the honor from their peers
Click here for the list.
New Emerging Scholar named
Scott Tomlins, M.D., an assistant profesor of pathology at U-M, has been designated the A. Alfred Taubman Emerging Scholar
U-M offers new early detection prostate cancer test
Research by Taubman Scholar Dr. Arul Chinnaiyan has let to the development of a new test for prostate cancer that is far more accurate than the standard PSA test, the University of Michigan has announced.
Click here to read more.
news & events
New Taubman Prize trophy debuts
The new trophy for the Taubman Prize for Excellence in Translational Medical Research, which was designed in consultation with institute founder Mr. A. Alfred Taubman, was presented at the institute's Oct. 11 symposium. The modern sculpture was created using a novel 3D printing technique.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.